High-Sensitivity C-Reactive Protein and Coronary Heart Disease in a General Population of Japanese

Author:

Arima Hisatomi1,Kubo Michiaki1,Yonemoto Koji1,Doi Yasufumi1,Ninomiya Toshiharu1,Tanizaki Yumihiro1,Hata Jun1,Matsumura Kiyoshi1,Iida Mitsuo1,Kiyohara Yutaka1

Affiliation:

1. From the Department of Environmental Medicine (H.A., M.K., K.Y., T.N., Y.T., J.H., Y.K.) and the Department of Medicine and Clinical Science (Y.D., K.M., M.I.), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Abstract

Objective— The purpose of this study was to investigate the effects of high-sensitivity C-reactive protein (hs-CRP) on the risks of coronary heart disease (CHD) in a general population of Japanese. Methods and Results— The Hisayama study is a population-based prospective cohort study. A total of 2589 participants aged 40 years or older were followed up for 14 years. Outcomes are incident CHD (myocardial infarction, coronary revascularization, and sudden cardiac death). The median hs-CRP level was 0.43 mg/L at baseline. During the follow-up period, 129 coronary events were observed. Age- and sex-adjusted annual incidence rates of CHD rose progressively with higher hs-CRP levels: 1.6, 3.3, 4.5, and 7.4 per 1000 person-years for quartile groups defined by hs-CRP levels of <0.21, 0.21 to 0.43, 0.44 to 1.02, and >1.02 mg/L, respectively ( P <0.0001 for trend). The risk of CHD in the highest quartile group was 2.98-fold (95% CI, 1.53 to 5.82) higher than that in the lowest group even after controlling for other cardiovascular risk factors. Conclusions— hs-CRP levels were clearly associated with future CHD events in a general population of Japanese. In Japanese populations, the hs-CRP cut-off point for high-risk of future development of CHD is likely to be >1.0 mg/L, which is much lower than that for Western populations.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. World Health Organization. The Atlas of Heart Disease and Stroke. Geneva: World Health Organization; 2004.

2. World Health Organization. Preventing Chronic Disease: A Vital Investment. Geneva: World Health Organization; 2005.

3. Trends in the Incidence, Mortality, and Survival Rate of Cardiovascular Disease in a Japanese Community

4. Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3